BSX - Boston Scientific - Stock Price & Dividends

Boston Scientific Corporation is a leading developer, manufacturer, and marketer of medical devices used in various interventional medical specialties worldwide. The company operates through two main segments: MedSurg and Cardiovascular.

In the MedSurg segment, Boston Scientific offers a range of devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, and single-use duodenoscopes. Additionally, the company provides devices to treat urological conditions, including ureteral stents, catheters, and holmium laser systems. Furthermore, Boston Scientific offers technologies to treat neurological movement disorders and manage chronic pain, including spinal cord stimulator systems and deep brain stimulation systems.

In the Cardiovascular segment, the company provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions. This includes the WATCHMAN FLX, a Left Atrial Appendage Closure Device, as well as implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers.

Boston Scientific also offers diagnosis and treatment solutions for rate and rhythm disorders of the heart, peripheral arterial and venous diseases, and products to diagnose, treat, and ease forms of cancer. With a strong commitment to innovation and patient care, the company has established itself as a leader in the medical device industry.

Founded in 1979, Boston Scientific is headquartered in Marlborough, Massachusetts, and has a strong online presence through its website, https://www.bostonscientific.com.